Drug Shortage Report for XIGDUO
Report ID | 72331 |
Drug Identification Number | 02449943 |
Brand name | XIGDUO |
Common or Proper name | dapagliflozin and metformin hydrochloride tablets |
Company Name | ASTRAZENECA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE Dapagliflozin |
Strength(s) | 1000MG 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 6 x 10 (blister) |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-01-28 |
Actual start date | |
Estimated end date | 2019-02-04 |
Actual end date | 2019-04-12 |
Shortage status | Resolved |
Updated date | 2019-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-01-15 | English | Compare |
v2 | 2019-01-15 | French | Compare |
v3 | 2019-01-29 | English | Compare |
v4 | 2019-04-16 | English | Compare |
v5 | 2019-04-16 | French | Compare |
Showing 1 to 5 of 5